• Ludwig Cancer Center Scientist Wins $3 Million Breakthrough Prize for ALS Discovery
  • ALS Affects More Brain Regions Than Just the Movement Control Area, Study Shows
  • ‘Strong Fighters,’ ALS Patients with Locked-in Syndrome Report Decent Quality of Life in Small Study
  • Seize the Day and Chase Winter Doldrums Away
  • NurOwn, Now in Phase 3 Trial, Shows Potential in ALS Patients with Rapid Progression, BrainStorm’s CMO Says in Interview
  • Poor Tolerability Leads to Failure of ALS Therapy Candidate Tirasemtiv in Phase 3 Trial
  • ALS Patients’ Lung-function Decline Scores Can Predict Breathing Failure, Study Reports
  • Radicava and Its Decisive Phase 3 Trial Among Presentations at ALS/MND Meeting This Weekend
  • Stem Cell Treatment Targeting Spinal Cord Won’t Slow ALS, Researchers Say
  • Takeda and Montreal Neurological Institute Team Up to Research New ALS Therapies
  • Join the ALS Boogie Board Club
  • VA Adds Radicava to its National Formulary for ALS Patients